Stem Cell Biomarkers and Drug Targets
Imaging
biomarkers permit prior
recognition of ailment contrasted with sub-atomic biomarkers, and smooth out
translational examination in the medication revelation commercial center. Since
they are mishmash, no body drug exists to assault them.
New
biomarker in disease stem cells that oversee
malignant growth endurance and spread, and it's raising expectation that drug
revelation to destroy malignancy stem cells.
With
the revelation that our human undifferentiated cell model had anticipated
precisely what was occurring in patients.